REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Szasz-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SZASZ-PHARMA GYOGYSZERTAR Bt. Profile Updated: November 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Szasz-Pharma Bt. is based in Hungary. The head office is in Ujszasz. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on August 21, 2002. The total number of employees is currently 15 (2024). In 2023, the company reported a net sales revenue increase of 20.19%. Its’ total assets recorded a growth of 0.73%.

Headquarters
Kossuth utca 41.
Ujszasz; Jasz-Nagykun-Szolnok; Postal Code: 5052

Contact Details: Purchase the Szasz-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Szasz-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Szasz-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Szasz-Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Szasz-Pharma Bt. report to view the information.
Incorporation Date:
August 21, 2002
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Szele Patika Bt.
Company Performance
Financial values in the chart are available after Szasz-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
20.19%▲
Total operating revenue
21.47%▲
Operating profit (EBIT)
N/A
EBITDA
-56.24%▼
Net Profit (Loss) for the Period
N/A
Total assets
0.73%▲
Total equity
-18.39%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.02%▲
Cash Ratio
0.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo